Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02156102 · ClinicalTrials.gov registry record
Insights Into Microbiome and Environmental Contributions to Sickle Cell Disease and Leg Ulcers Study (INSIGHTS Study)
A clinical trial of Genetic Disease and Genomics, sponsored by National Human Genome Research Institute (NHGRI).
- Completed
- Registry status
- 405
- Enrollment target
- 3
- Study locations
NCT02156102 is a study of Genetic Disease and Genomics that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 405 participants, below the 2,548-participant average among 30 other Genetic Disease trials with a reported enrollment target (84% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT02156102, a study of Genetic Disease and Genomics, has completed, sponsored by National Human Genome Research Institute (NHGRI).
- COMPLETED
- Registry status
- 405 participants
- Enrollment target
- 3
- Study locations
Study Summary
Background: \- People with sickle cell disease and other blood disorders sometimes get chronic leg ulcers. These are wounds that develop on the skin and don t go away. Current treatments do not work very well, so researchers want to learn more about why the ulcers happen. They want to find out which bacteria may cause it, and if external factors play a role. Objective: \- To study social and environmental factors of sickle cell disease and the causes of sickle cell disease leg ulcers. Eligibility: \- People age 18 and older who have sickle cell disease or another red cell disorder, with or without an active leg ulcer. Design: * Participants will have a medical history and clinical evaluation. They will also have blood drawn. * Participants will complete questionnaires about their life, health, environment, stress, and other topics. * Participants may provide a small sample of hair. * Participants will be asked to collect a small amount of saliva. * Participants with leg ulcers will have their skin microbiome sampled. The microbiome is all of the microbes (bacteria and and/or fungi) and their genes in and on the body. Researchers will use swabs to collect skin samples. Photographs will be taken of the skin sample area. * Some participants without leg ulcers also will have their skin microbiome sampled. * Some participants who have their skin microbiome sampled will return for a second visit. At this visit, their microbiome will be resampled. It will take place more than 30 days after the first visit.
Conditions Studied
Study Locations (3)
Maryland
- National Institutes of Health Clinical Center - Bethesda
New York
- Montefiore Medical Center/Albert Einstein College of Medicine - The Bronx
Other
- University of Sierra Leone, College of Medicine and Allied Health Services - Freetown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 405 participants |
| Start Date | 2014-06-16 |
| Est. Completion | 2024-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02156102
The ClinicalTrials.gov registry entry for NCT02156102 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 405 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,548-participant average among 30 other Genetic Disease trials with a reported enrollment target (84% lower). The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Genetic Disease appearing as the primary indexed condition, and to 0 interventions.
NCT02156102 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Maryland, New York, Other.
Frequently Asked Questions
What is clinical trial NCT02156102 about?
NCT02156102 is a clinical study titled "Insights Into Microbiome and Environmental Contributions to Sickle Cell Disease and Leg Ulcers Study (INSIGHTS Study)". Background: \- People with sickle cell disease and other blood disorders sometimes get chronic leg ulcers. These are wounds that develop on the skin and don t go away. Current treatments do not work very well, so researchers want to learn more about why the ulcers happen. They want to find out whic...
What is the current status of trial NCT02156102?
This trial is currently completed. The enrollment target is 405 participants. The study started on 2014-06-16. Estimated completion is 2024-10-01.
What conditions does trial NCT02156102 study?
This clinical trial studies the following conditions: Genetic Disease, Genomics.
Who is sponsoring clinical trial NCT02156102?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02156102 being conducted?
This trial has 3 study locations across Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genetic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Adaptive Clinical Trial of BeginNGS Newborn Screening for Hundreds of Genetic Diseases by Genome Sequencing
RECRUITING · NA
-
Delineating the Molecular Spectrum and the Clinical, Imaging and Neuronal Phenotype of Chopra-Amiel-Gordon Syndrome
RECRUITING
-
Rett Syndrome Registry
RECRUITING
-
Natural History Study of Patients with HPDL Mutations
RECRUITING
-
Diagnostic Odyssey: Whole Genome Sequencing (WGS)
RECRUITING
-
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.